Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.
• NP344254.RAq-7JW847Gy4FdznePoslQel79oNoXve9zw8vvKhiBl0130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344254.RAq-7JW847Gy4FdznePoslQel79oNoXve9zw8vvKhiBl0130_provenance.
• NP239255.RAt_420b3Cv94BJOqRJXs0Z9m2C7nXUHw8-0792HnC550130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239255.RAt_420b3Cv94BJOqRJXs0Z9m2C7nXUHw8-0792HnC550130_provenance.
• NP437589.RAoYSW7xrVVTjoQC2r4yQcMa2NBgi0qmIwB62fzbcEFSU130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437589.RAoYSW7xrVVTjoQC2r4yQcMa2NBgi0qmIwB62fzbcEFSU130_provenance.
• NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431581.RA_uKWx94V0HrM7vbkeceakKyin-_09SdCKbgh2rhsPzQ130_provenance.
• assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP869882.RARQ8hGoMHlExHQ3sOFPRww31gTRNysFoRQvuoJwFpNf8130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869882.RARQ8hGoMHlExHQ3sOFPRww31gTRNysFoRQvuoJwFpNf8130_provenance.
• NP771691.RAKi5y7CVRoFu_eRyuKIcEv9yIFbioiCaAV8BklaWd9Z0130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771691.RAKi5y7CVRoFu_eRyuKIcEv9yIFbioiCaAV8BklaWd9Z0130_provenance.
• NP869884.RAD0zAEXrr_bcvYi4VE-sAPM2KamBLow4T7b4qtc48z4w130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869884.RAD0zAEXrr_bcvYi4VE-sAPM2KamBLow4T7b4qtc48z4w130_provenance.
• NP519087.RAN60EhG_tKMuCWV0oxggtcpYNoisOIc-GX5F9PrAJCWc130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519087.RAN60EhG_tKMuCWV0oxggtcpYNoisOIc-GX5F9PrAJCWc130_provenance.
• NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519090.RANn8PLhC1Ul6s2UZIoXt0M4-PKWLSgXNTt_9qjA0NwJg130_provenance.
• NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519018.RAyA0PYUxHk1_49mVmoFcEFRfjDoCPDn3pMIqZwWbC1pU130_provenance.
• NP717230.RAO3ASKW5H5oR6VVIYBoXZngJNblqFDU58KIZFH4Avv_I130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717230.RAO3ASKW5H5oR6VVIYBoXZngJNblqFDU58KIZFH4Avv_I130_provenance.
• NP869885.RAIVquAdn6QcVqeaQqqWuhVUAq2CJvJ15oVojG2qh0AuU130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869885.RAIVquAdn6QcVqeaQqqWuhVUAq2CJvJ15oVojG2qh0AuU130_provenance.
• NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.